Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01098292 · ClinicalTrials.gov registry record
Observational Study of Control Participants for the MAPP Research Network
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 615
- Enrollment target
NCT01098292: Completed study, sponsored by University of Pennsylvania.
NCT01098292 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 615 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01098292 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 615 participants
- Enrollment target
Study Summary
The Control Study for the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network has been established to focus on a broader approach to the study of Interstitial Cystitis (IC)/Painful Bladder Syndrome (PBS) in men and women, and Chronic Prostatitis (CP)/Chronic Pelvic Pain Syndrome (CPPS) in men, than previously undertaken. Participants with no Urologic Pelvic Pain Syndromes as well as participants with specific conditions (Fibromyalgia (FM), Irritable Bowel Syndrome (IBS), Chronic Fatigue Syndrome (CFS)) are being recruited for the Trans-MAPP Control Study. These participants will act as a reference/control group for the Trans-MAPP Epidemiology \& Phenotyping (EP) Study. As with many chronic pain disorders, IC and CP are poorly understood, and treatment is often not helpful. The goal of this study is to better understand how pain is felt in people with IC or CP. The MAPP Control Study is an observational study that will enroll participants from 6 Discovery Sites and 3 Satellite Sites across the U.S. The investigators will ask questions and gather information about the health and life of the participants for research purposes. The investigators hope that this study will lead to improvement in the treatment of IC and CP.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 615 participants |
| Start Date | 2009-12 |
| Est. Completion | 2014-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01098292
The ClinicalTrials.gov registry entry for NCT01098292 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 615 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01098292 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01098292 about?
NCT01098292 is a clinical study titled "Observational Study of Control Participants for the MAPP Research Network". The Control Study for the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network has been established to focus on a broader approach to the study of Interstitial Cystitis (IC)/Painful Bladder Syndrome (PBS) in men and women, and Chronic Prostatitis (CP)/Chronic Pelvic...
What is the current status of trial NCT01098292?
This trial is currently completed. The enrollment target is 615 participants. The study started on 2009-12. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT01098292?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.